Putnam Investments’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
CIP
FLAM
FAM
Putnam Investments's ATRC Position: Q4 2023 in Review
Putnam Investments increased its AtriCure (ATRC) stake by 23% in Q4 2023, buying an estimated $230K and bringing the position to 33,708 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #823.
Putnam Investments first reported a position in ATRC in Q1 2014 and has held it in 20 quarters since. The position peaked at $7.59M in Q4 2014. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2023.
- Putnam Investments held 33,708 shares of AtriCure worth $1.2M as of Q4 2023.
- Putnam Investments bought 6,196 AtriCure shares in Q4 2023, an estimated $230K.
- AtriCure made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #823 holding.
- Putnam Investments first reported a position in AtriCure in Q1 2014 and has held it in 20 quarters since.
- Putnam Investments's AtriCure position peaked at $7.59M in Q4 2014.
- 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.